课题基金 / 基金详情

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
项目总结/摘要 人类致畸剂课程 《人类致畸剂课程》(The Human Teratogens Course),Sarah G. Običan,MD,是由 南佛罗里达大学(USF)健康,出生缺陷研究和预防协会 (BDRP)和畸形学信息专家组织(奥蒂斯)。人类 致畸剂课程是一个为期三天的教育会议,几乎每两年举行一次。下一 课程将于2023年11月13日至15日举行。人类致畸剂课程是一个独特的 教育机会,旨在提高医疗保健提供者的知识和技能, 人类畸形学领域该课程针对医疗保健专业人员, 参与照料孕妇或哺乳期妇女及其婴儿的受训人员。 这些医疗保健专业人员包括但不限于产科医生,妇科医生, 围产期专家、产科医生、儿科医生、遗传咨询师、致畸信息 专家和药剂师。研究人员和科学家也可能对该课程感兴趣 从事畸形学研究该课程将由一个专家教师团队领导 并包括讲座,将涵盖畸形学,胚胎学,流行病学, 以及致畸风险评估和沟通。该课程还将提供最新的 关于提供者在其实践中可能遇到的各种风险的信息。的 课程旨在为参与者提供他们可以识别,评估, 并管理孕妇及其婴儿的暴露,最终导致 改善这些人的结果。该课程以前是在坦帕亲自举办的, 2019年的佛罗里达和2021年的虚拟。虚拟课程吸引了来自30个不同国家的参与者 以及15个不同的国家。即将到来的课程将是一个虚拟的活动, 介绍。虚拟形式将使来自不同地点的与会者能够参加。的 虚拟形式还将包括互动问答环节, 参与者之间的互动。
英文摘要
Project Summary/Abstract Human Teratogens Course The Human Teratogens Course, directed by Sarah G. Običan, MD, is co-sponsored by the University of South Florida (USF) Health, the Society for Birth Defects Research and Prevention (BDRP), and the Organization of Teratology Information Specialists (OTIS). The Human Teratogens Course is a three-day educational meeting held virtually every two years. The next Course will take place November 13-15, 2023. The Human Teratogens Course is a unique educational opportunity that aims to enhance the knowledge and skills of healthcare providers in the field of human teratology. The course is targeted toward healthcare professionals and trainees involved in the care of people who are pregnant or lactating as well as their infants. These healthcare professionals include but are not limited to, obstetricians, gynecologists, perinatologists, neonatologists, pediatricians, genetic counselors, teratogen information specialists, and pharmacists. The course may also be of interest to researchers and scientists involved in the field of teratology. The course will be led by a team of expert faculty members and consist of lectures that will cover basic principles of teratology, embryology, epidemiology, and teratogen risk assessment and communication. The course will also provide up-to-date information on various exposures that providers are likely to encounter in their practice. The course aims to provide participants with the tools and resources they may to identify, evaluate, and manage exposures in people who are pregnant and their infants, ultimately leading to improved outcomes for these individuals. The course was previously held in person in Tampa, Florida in 2019 and virtually in 2021. The virtual course drew participants from 30 different States as well as 15 different countries. The upcoming course will be a virtual event with live presentations. The virtual format will enable participants from different locations to attend. The virtual format will also include interactive question-and-answer sessions that will facilitate engagement among participants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金